Skip to main content
ME

Mereo Biopharma

London, United Kingdom
Last funding
$50.0M
Post-IPO EquityJun 2024

Mereo is a new UK-based speciality biopharmaceutical company.

About Mereo Biopharma

How much funding has Mereo Biopharma raised?

Mereo Biopharma has raised $50.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.

Who are Mereo Biopharma's investors?

Mereo Biopharma's investors include Vivo Capital, Janus Henderson Investors, Perceptive Advisors, Samsara BioCapital, Rock Springs Capital.

Where is Mereo Biopharma headquartered?

Mereo Biopharma is headquartered in London, United Kingdom.

What does Mereo Biopharma do?

Mereo is a new UK-based speciality biopharmaceutical company.

What stage is Mereo Biopharma at?

Mereo Biopharma is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Mereo Biopharma — Funding & Investors." VCBacked, June 14, 2024, https://www.vcbacked.co/company/mereo-biopharma. Accessed November 13, 2026.
APA
VCBacked. (2024). Mereo Biopharma — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/mereo-biopharma
Wikipedia (cite web)
{{cite web |title=Mereo Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/mereo-biopharma |website=VCBacked |access-date=November 13, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Mereo Biopharma? Request a listing update

Founder contacts
m***@mereobiopharma.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →